Max Healthcare Institute Ltd, one of India’s largest healthcare organizations, has joined a prestigious international consortium under the Indo-European COMBAT initiative. This collaboration aims to advance dengue research and strengthen global pandemic preparedness. Supported by the Department of Biotechnology and the European Commission, the initiative brings together leading institutions from India and Europe to develop technology-driven solutions for managing mosquito-borne diseases.
Landmark Grant to Drive Research
As reported by Pharmabiz, the consortium has secured a significant grant to support this ambitious research programme. Through this funding, participating institutions will work to improve the understanding, diagnosis, and management of dengue and related infectious diseases.
Strong Clinical and Research Leadership
Max Healthcare contributes to the initiative through its principal investigators, Dr. Sandeep Budhiraja, Group Medical Director, and Dr. Atul Thatai, Director – Molecular Diagnostics and Cytogenomics. Together, they provide clinical expertise and research leadership.
At the same time, Dr. Ujjwal Neogi, Associate Professor at the Karolinska Institute, has facilitated this collaboration. In India, the project is being led by the BRIC National Institute of Biomedical Genomics, ensuring strong scientific coordination.
Leveraging Advanced Technologies
The project integrates multi-omics technologies, clinical data, and artificial intelligence to deepen the understanding of disease progression. Furthermore, it aims to identify predictive biomarkers and enable early, precise interventions for dengue and similar infectious diseases. As a result, researchers expect to improve both diagnosis and patient outcomes.
Expert Perspectives on the Collaboration
Dr. Sandeep Budhiraja highlighted the importance of the initiative, noting that dengue continues to pose a major public health challenge in India. He emphasized that combining clinical expertise with advanced technologies will enhance early diagnosis and improve patient care. Moreover, he described the collaboration as a crucial step toward building more resilient healthcare systems.
In addition, Dr. Ujjwal Neogi underscored the global significance of the partnership. He stated that the initiative unites Europe’s scientific capabilities with India’s clinical strengths to create data-driven, scalable solutions. Such collaborations, he added, are essential for strengthening global preparedness against future health threats.
Strengthening Global Research and Preparedness
Max Healthcare’s participation reflects its growing presence in global research ecosystems and its commitment to advancing evidence-based, technology-driven healthcare. As dengue continues to affect populations across tropical regions, the COMBAT initiative is expected to serve as a model for international collaboration.
Ultimately, by combining innovation, data, and shared expertise, the initiative aims to deliver scalable solutions while enhancing preparedness for future pandemics.